Breaking News

2 days ago: Park Forest’s Sandra Zoellner Retires After 21 Years of Service
2 days ago: Save the date for The Prairie Party at theNate
2 days ago: Governors State Has New Soccer Complex and New Men’s Coach
1 week ago: Wilmington Man’s Photo of Rare Snowy Egret Wins Forest Preserve Photo Contest
2 weeks ago: Amauree Williams Caps Historic Southland Career with Three State Championships

Health and Fitness

Northwestern Medicine Enrolls First Participant in Midwest for Research Study of Personalized Vaccine for Aggressive Brain Tumors

by Gary Kopycinski on August 15, 2013

Gary Kopycinski Author

More in Health and Fitness:

On Hantavirus, Park Forest Officials Urge Caution May 18, 2026
Rep. Kelly Condemns FDA Approval of Flavored E-Cigarettes May 6, 2026
Park Forest Aligns With Illinois Guidance on Childhood Vaccines Amid Federal Changes January 11, 2026

Randomized phase II trial will investigate vaccine therapy combined with Avastin for patients with recurrent glioblastoma multiforme